Our Bodies, Ourselves, a succession to a pamphlet of resources pulled from co-ops of women in and around Boston, Massachusetts was published in New York in 1973 by Simon and Schuster. Retitled from the original Women and Their Bodies, Our Bodies, Ourselves was an effort by a group of educated, middle class women to reinforce women's ownership of their bodies. There have been eight editions of Our Bodies, Ourselves, as well as sequels such as Our Bodies, Ourselves: Pregnancy and Birth and Our Bodies, Ourselves: Menopause. Our Bodies, Ourselves has sold more than four million copies and been printed in twenty foreign-language editions.

In 1904, physician William Henry Walling published Sexology, a family medicine reference book. In his book, Walling proposed that his guidance would help people who were married or single and young or old, as well as anyone who wanted to conform to, what he claims are, gender expectations. Sexology discusses issues such as masturbation, abortion, pregnancy, labor, and marriage. Despite Walling’s limited scientific explanations and evidence for his medical claims, the Puritan Publishing Company printed and distributed the book, which received many positive reviews and endorsements from other physicians, college presidents, politicians, and religious leaders. However, in the twenty-first century, people may consider many of Walling’s claims to be sexist and oppressive toward women. Sexology provides readers with examples of historical medical misconceptions of male and female anatomy and provides context for the logic of reproductive medicine at the turn of the twentieth century.

In 1950, physician and researcher Ernst Gräfenberg published “The Role of Urethra in Female Orgasm,” in the International Journal of Sexology. The article was one of the first to mention the area in the anterior, or front, vaginal wall colloquially called the G-spot. In the article, Gräfenberg acknowledges that many females experience problems related to sexual satisfaction, and he argues that researchers and physicians of the time did not know enough information about the anatomical mechanisms and localization of the female orgasm to help them. He claims that there is a distinct zone in the anterior vaginal wall along the urethra that plays a critical role in female sexual pleasure, making it important for physicians to consider when treating females’ sexual problems. Though researchers are still debating the structural existence of the G-spot as of 2022, “The Role of Urethra in Female Orgasm” was one of the first publications to explore the anatomical elements of the female orgasm, and it led to further research about female sexuality that has helped many individuals to better understand female pleasure.

In 2002, the Writing Group for the Women's Health Initiative Investigators published the article Risks and Benefits of Estrogen Plus Progestin in Healthy, Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial in The Journal of the American Medical Association. In the article, the authors report on the Women's Health Initiative, which was a study initiated by the National Institutes of Health to determine the effects of hormone therapy in postmenopausal women, or women whose menstrual cycles have stopped, from the ages of fifty to seventy-nine. The researchers attempted to determine if a link existed between a common type of hormone therapy, a combination of estrogen and progestin, and prevalent diseases in postmenopausal women, including cardiovascular disease and cancer. As reported by the authors in their article, the researchers discontinued the study after five years when they found that there were many risks associated with the use of estrogen plus progestin hormone therapy, including increased risks of breast cancer and heart diseases.

Between 1958 and 1962, physicians Olive W. Smith, George V. Smith, and Robert W. Kistner performed experiments that demonstrated the effects of the drugs MER-25 and clomiphene citrate on the female human body. MER-25 and clomiphene citrate are drugs that affect estrogen production in women. At the time of the experiment, researchers did not know which organ or organs the drugs affected, the ovaries and/or the anterior pituitary gland. To determine that, the physicians reviewed nine of their own previous studies in women in which they measured the urinary output of hormones after the administration of either drug. Based on their examination the researchers concluded that MER-25 appeared to influence the anterior pituitary gland in the brain to produce a response in the ovaries and that clomiphene citrate appeared to act on the ovaries. Their results provided early evidence about the mechanisms of both drugs. Later, clomiphene citrate became a common fertility drug.

The figure depicts three different molecular structures of estrogen found in mammals’ that differ by the arrangement of bonds and side groups. The molecular structures of the three estrogen molecules differ by the arrangement of chemical bonds and side groups attached to the core steroid structure, cholesterol, which contains three cyclohexane rings and one cyclopentane ring.

Hormone replacement therapy, or HRT, is a form of medication often used to treat the symptoms of menopause. According to the National Institute on Aging, menopause is the point in a female’s life twelve months after she has had her last period. The time leading up to menopause, often called perimenopause, is a transition stage when levels of sex hormones, namely estrogen and progesterone, begin to fall. For approximately eighty-five percent of menopausal females, that decline results in symptoms such as vaginal dryness, shifting moods, and hot flashes, or an abrupt feeling of warmth typically in the upper body. HRT replenishes a person’s sex hormones, and though there are many methods of HRT, people most commonly take a pill that contains either estrogen only or both estrogen and progesterone. HRT has evolved scientifically but has at times resulted in controversy over potential side effects. Despite historical controversy, as of 2024, researchers recognize that with careful consideration of an individual's health conditions and history, HRT can be an effective treatment for menopausal symptoms.

In 1991, the US National Institutes of Health, or NIH, launched the Women’s Health Initiative, or WHI, which is one of the largest and one of the first long-term, nationwide studies of health conditions affecting postmenopausal females in the United States. Menopause is defined as the point in time twelve months after a female has had her last menstrual period. After menopause, females face higher risks of certain conditions, such as cardiovascular diseases. In 1991, Bernadine Healy, a physician who studied cardiology, became the first female director of the NIH and founded the WHI because she observed that research into female health was lacking. The WHI initiated several clinical trials to study whether changing diet, taking supplements, or undergoing hormone therapy could alleviate menopause symptoms. The trial of hormone therapy identified risks associated with that treatment and generated controversy. Despite the controversy, the WHI was one of the first organizations to produce comprehensive research into treatments and preventative methods for menopause symptoms, thereby improving healthcare options for postmenopausal females. 

Menopause is defined as the point in time exactly twelve months after a female has had her last menstrual period, or shedding of the lining of the uterus. As a female ages, the hormone levels that drive menstruation decrease, beginning the process of perimenopause, which eventually leads to menopause and can result in various symptoms including depression, difficulty sleeping, and hot flashes, or abrupt feelings of heat typically in the upper body. Once a female reaches menopause, those symptoms typically subside, but after menopause, the risk of other health conditions such as osteoporosis, or brittle bones, increases. At least since the fourth century BCE, researchers understood that menopause occurred in females but held many negative ideas and misconceptions about the process, which resulted in stigma that left females uninformed about what happened to their bodies as they aged. Research on and perceptions towards menopause evolved over the twentieth century, and as of 2024, researchers understand it as a typical part of aging and development in females, marking the end of their reproductive years.